中文 | English
Return
Total: 658 , 1/66
Show Home Prev Next End page: GO
Author:(Ning LUO)

1.Expression and clinical significance of CD40 protein in human bladder cancer tissue

Ning YANG ; Zhigang LUO

Cancer Research and Clinic 2010;22(4):219-221

2.Gene polymorphism of fibrinogen: Is it an independent ris factor of ischemic stroke

Ning LUO ; Yuji WU

Chinese Journal of Tissue Engineering Research 2006;10(30):190-192

3.Analysis of the efficacy of pirarubicin combined with paclitaxel in the treatment of three negative breast cancer

Ning LUO ; Feifei WU

Chinese Journal of Biochemical Pharmaceutics 2017;37(7):180-181

4.Chemotherapy and tumor immunogenic cell death

Cong LUO ; Ning TAO

Journal of International Oncology 2017;44(5):369-372

5.Nutritional risk relates to the prognosis of patients with retroperitoneal liposarcoma

Ning NING ; Boyuan ZOU ; Chenghua LUO ; Yingjiang YE ; Xiaodong YANG

Chinese Journal of General Surgery 2016;31(3):218-220

6.Establishment of New Model of Pharmaceutical Care in Community

Ning LUO ; Sihan ZHANG ; Weiqian CAI

China Pharmacy 1991;0(01):-

7.Strengthening scientific and technological management so as to enhance the core competitiveness of the hospital

Mingyue LUO ; Fangqin NING ; Gang LI

Chinese Journal of Hospital Administration 1996;0(05):-

8.The value of spiral CT and image post-processing in the evaluation of laryngeal carcinoma

Jianwei WANG ; Ning WU ; Dehong LUO

Chinese Journal of Radiology 2000;0(12):-

9.Role of nitric oxide in ischemia/reperfusion injury and ischemic preconditioning

Xiangying JIAO ; Ning LUO ; Rongrui ZHAO

Chinese Journal of Pathophysiology 2000;0(10):-

10.Guiding value of systemic vascular resistance index for vasoactive drugs used in septic shock patients

Ning YE ; Xueping LUO ; Shanyang SHI

Chongqing Medicine 2014;(2):179-181

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 658 , 1/66 Show Home Prev Next End page: GO